Status:
RECRUITING
Anticipating Decline and Providing Therapy
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Cognitive Impairment
Dementia
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
This pilot feasibility study will be a randomized control trial of usual care following Intensive Care Unit (ICU) discharge compared to the Anticipating Decline and Providing Therapy (ADAPT) screening...
Detailed Description
Anticipating Decline and Providing Therapy (ADAPT) is a program designed to support the implementation of a routine post-ICU cognitive impairment screening and support intervention. The program includ...
Eligibility Criteria
Inclusion
- Age 60 and older at time of discharge from intensive care unit
- Minimum 72 hour Intensive Care Unit stay in an ICU at Atrium Health Wake Forest Baptist
- Delirium during ICU stay as determined by positive Confusion Assessment Method (CAM)-ICU score, review of clinical - documentation, or discussion with clinical team
- Primary care provider in the Atrium Health Wake Forest system or intention to follow with Primary Care Physician in Atrium Health system
- English speaking
Exclusion
- Death during initial hospitalization and/or discharge to Hospice
- Life-expectancy \< 6 months from pre-existing illness (defined as diagnosis of metastatic cancer, cirrhosis, advanced heart failure, prior palliative care referral)
- Acute Traumatic Brain Injury
- Continued residence in skilled nursing facility or rehab that prevents ability to complete study telephone call at time of first cognitive screen attempt
- Prior history of dementia in electronic health record
- Language or communication barrier that prohibits intervention participation
- Participant cannot identify family or caregiver contact or family/caregiver unwilling to participate
- Subject or legally authorized representative (LAR) decline consent
- Unstable telephone service for contact after hospital discharge
- Primary residence outside of North Carolina
Key Trial Info
Start Date :
March 8 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06182995
Start Date
March 8 2024
End Date
November 30 2026
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina, United States, 27157